Denosumab and zoledronic acid treatment in patients with genitourinary cancers and bone metastases

被引：0
|
作者：
Costa, Luis
Fizazi, Karim
Saad, Fred
Brown, Janet Elizabeth
Von Moos, Roger
Oudard, Stephane
Sternberg, Cora N.
Ganju, Vinod
Miller, Kurt
Wang, Huei
Maniar, Tapan
Braun, Ada
机构：
[1] Hosp Santa Maria, Lisbon, Portugal
[2] Inst Med Mol, Lisbon, Portugal
[3] Univ Paris Sud, Inst Gustave Roussy, Villejuif, France
[4] Univ Montreal Hosp Ctr, CRCHUM, Montreal, PQ, Canada
[5] Canc Res UK Clin Ctr, Leeds, W Yorkshire, England
[6] Kantonsspital Graubunden, Chur, Switzerland
[7] Georges Pompidou European Hosp, Paris, France
[8] San Camillo Forlanini Hosp, Rome, Italy
[9] Peninsula Oncol Ctr, Frankston, Australia
[10] Charite, D-13353 Berlin, Germany
[11] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5079
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Zoledronic acid (ZOMETA): a significant improvement in the treatment of bone metastases
    Nagy, Z
    PATHOLOGY & ONCOLOGY RESEARCH, 2005, 11 (03) : 186 - 187
  • [42] Comparison between zoledronic acid and clodronate in the treatment of prostate cancer patients with bone metastases
    Feng Wang
    Wei Chen
    Hongde Chen
    Licai Mo
    Haiyong Jin
    Zhixian Yu
    Chengdi Li
    Qing Liu
    Feifei Duan
    Zhiliang Weng
    Medical Oncology, 2013, 30
  • [43] Zoledronic acid for the treatment of bone Metastases in patients with breast cancer and other solid tumors
    Lacerna, L
    Hohneker, J
    SEMINARS IN ONCOLOGY, 2003, 30 (05) : 150 - 160
  • [44] Comparison between zoledronic acid and clodronate in the treatment of prostate cancer patients with bone metastases
    Wang, Feng
    Chen, Wei
    Chen, Hongde
    Mo, Licai
    Jin, Haiyong
    Yu, Zhixian
    Li, Chengdi
    Liu, Qing
    Duan, Feifei
    Weng, Zhiliang
    MEDICAL ONCOLOGY, 2013, 30 (03)
  • [45] New and Emerging Therapies for Bone Metastases in Genitourinary Cancers
    Saylor, Philip J.
    Armstrong, Andrew J.
    Fizazi, Karim
    Freedland, Stephen
    Saad, Fred
    Smith, Matthew R.
    Tombal, Bertrand
    Pienta, Kenneth
    EUROPEAN UROLOGY, 2013, 63 (02) : 309 - 320
  • [46] Zoledronic acid and atrial fibrillation in cancer patients with bone metastases
    Aksoy, S.
    Dizdar, O.
    Turgut, D.
    Dede, D. Sener
    Arslan, C.
    Harputluoglu, H.
    Altundag, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [47] Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases
    Chen, TL
    Berenson, J
    Vescio, R
    Swift, R
    Gilchick, A
    Goodin, S
    LoRusso, P
    Ma, PM
    Ravera, C
    Deckert, F
    Schran, H
    Seaman, J
    Skerjanec, A
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (11): : 1228 - 1236
  • [48] Zoledronic acid for the prevention of bone metastases in patients with breast cancer
    Coleman, R.
    Gralow, J.
    Bell, R.
    Lipton, A.
    EJC SUPPLEMENTS, 2004, 2 (03): : 74 - 75
  • [49] Cryoablation combined with zoledronic acid in comparison with cryoablation and zoledronic acid alone in the treatment of painful bone metastases
    Li, Fenqiang
    Wang, Wenhui
    Li, Li
    Su, Dongjun
    Chang, Yaowen
    Guo, Gang
    He, Xuewen
    Li, Baohua
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 8 (02) : 539 - 544
  • [50] NUMBER NEEDED TO TREAT AND RISK BENEFIT ANALYSIS OF DENOSUMAB VERSUS ZOLEDRONIC ACID IN THE TREATMENT OF CASTRATE-RESISTANT PROSTATE CANCER PATIENTS WITH BONE METASTASES
    Xie, Jipan
    Diener, Melissa
    Wu, Eric
    Sorg, Rachael
    Yu, Andrew
    Namjoshi, Madhav
    JOURNAL OF UROLOGY, 2012, 187 (04): : E74 - E74
12345